-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
In recent years, China's medical reform has continued to unleash good results, and the rapid development of the private medical sector has attracted international medical service providers to accelerate the layout of the Chinese market. Singapore enterprise health care provider Fuller Medical announced in Shanghai on the 28th the introduction of Ping An Insurance (Group) Co., Ltd. (China Ping An) under the core equity investment platform Ping An Capital Co., Ltd. (Ping An Capital) investment, to accelerate the expansion of the Chinese market.Xin Dawei, vice chairman of
Fuller Healthcare Group, said ping an investment team would lead the completion of the investment in Fuller Healthcare, with an investment of more than 800 million yuan, making Ping An Capital and its affiliates the second largest shareholder in Fuller Healthcare. This partnership will help Fuller Medical grow in the Chinese market.
Liu Dong, chief partner of Ping An Capital, said that In addition to investing capital, Ping An Capital will coordinate Ping An Group's medical resources, including Ping An Health Insurance, Ping An Good Doctor, Wanjia Medical and other sectors, to help Fuller Medical expand its business in the Chinese market.
is very optimistic about the huge opportunities in China's private healthcare market and in the entire healthcare reform process. China's corporate health management market will grow from $5.7 billion in 2010 to $21.1 billion by 2020, according to a 2016 study by Frost Sullivan.
said Fuller Medical is now planning to use existing insurance and corporate customer resources to speed up the chinese market business layout. As a first step into China, Fuller Medical plans to open about 100 clinics in Beijing, Shanghai and Guangzhou. Fuller Medical is also actively promoting cooperation with many Chinese companies.
Believes that in China, there is a large gap between general public and expensive private medical services, affordable high-quality medical services, so in China is mainly located in this mass market. In China, a rapidly aging population, cost control has become a key issue in the development of the healthcare industry, and scale and technology are the two keys to cost control.
believes that China is an important market in the Asia-Pacific region, which is not only large in size, but also has some unique development advantages, such as technological advantages. In some respects, China's technological infrastructure has developed far beyond some developed countries such as Europe and the United States, such as instant messaging software and internet payments, which provide good conditions for the application of medical technology, such as medical payments, using the cloud as a prescription or storing patient medical information. (Economic Reference)